Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 2.19 USD -2.23% Market Closed
Market Cap: 195.4m USD

Net Margin
Oncology Institute Inc

-13.1%
Current
-11%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-13.1%
=
Net Income
-52.8m
/
Revenue
403.2m

Net Margin Across Competitors

Oncology Institute Inc
Glance View

Market Cap
194.8m USD
Industry
Health Care

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

TOI Intrinsic Value
2.98 USD
Undervaluation 26%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-13.1%
=
Net Income
-52.8m
/
Revenue
403.2m
What is the Net Margin of Oncology Institute Inc?

Based on Oncology Institute Inc's most recent financial statements, the company has Net Margin of -13.1%.

Back to Top